Lifecore Biomedical Expects FY25 Revenue Of $126.5M - $130M, Adjusted EBITDA Of $19M - $21M
Portfolio Pulse from Benzinga Newsdesk
Lifecore Biomedical has announced its financial expectations for fiscal year 2025, projecting revenue between $126.5 million and $130 million, and adjusted EBITDA between $19 million and $21 million.
August 26, 2024 | 9:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Lifecore Biomedical has provided its financial outlook for FY25, expecting revenue between $126.5M and $130M, and adjusted EBITDA between $19M and $21M. This guidance could influence investor sentiment positively.
The announcement of revenue and EBITDA projections provides a clear financial outlook, which is likely to positively influence investor sentiment. The guidance suggests growth and stability, which are attractive to investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100